Search

everythinglearnresearchcommunity

for

Search:↓

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

CCCA can affect both genders and all ages, and it has a genetic component.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

CT60 polymorphism might increase the risk of Alopecia Areata.

Keratoacanthoma changes as it grows, showing different hair follicle characteristics at each stage.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

There is no standard treatment for CCCA, and practices vary widely.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

CK 19 expression is higher in more severe skin cancers.

α- and γ-catenins help develop fetal skin by 23 weeks.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

CCCA can appear as patchy hair loss in younger men, not just the usual pattern.

The program increased awareness of traction alopecia but didn't significantly change hairstyling habits.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Changes in early neurosteroid levels can affect adult learning and anxiety.

The exam tested knowledge on various skin-related topics for CME credit.

C-scores can help predict gain-of-function and loss-of-function mutations.